| BRAND NAME |
| GLICNOM-MV |
| COMPOSITION |
GLICAZIDE 80MG+ METFORMIN 500MG+ VOGLIBOSE 0.3MG |
| PACKING TYPE |
| ALU ALU |
| PACKING SIZE |
| 10x15 |
GLICNOM-MV is a triple-combination anti-diabetic tablet formulated with Gliclazide 80 mg, Metformin 500 mg, and Voglibose 0.3 mg for the effective management of Type 2 Diabetes Mellitus. This advanced formulation helps control blood glucose levels through multiple mechanisms, providing comprehensive glycemic control in patients whose blood sugar levels are not adequately managed with diet, exercise, or single-drug therapy.
Gliclazide stimulates insulin secretion from the pancreas, Metformin reduces glucose production in the liver and improves insulin sensitivity, while Voglibose delays carbohydrate absorption in the intestine, helping control post-meal blood sugar spikes. Together, these ingredients offer balanced and sustained blood glucose management.
Here are some of the key features of the Gliclazide 80 mg, Metformin 500 mg, and Voglibose 0.3 mg tablets
The Gliclazide 80 mg, Metformin 500 mg, and Voglibose 0.3 mg tablet is indicated for using int he following conditions:
Here are some of the key features of the GLICNOM-MV Tablet the brand of Gliclazide 80 mg, Metformin 500 mg, and Voglibose 0.3 mg tablets manufactured by DM Pharma are :
Take GLICNOM-MV as prescribed by a healthcare professional. The dosage should be individualized based on the patient’s blood glucose levels and clinical response.
Storage Instructions
Available in blister packs with secure pharmaceutical-grade packaging to ensure product quality, stability, and patient convenience.
GLICNOM-MV is a reliable anti-diabetic medication designed to provide comprehensive blood sugar control and support healthier diabetes management.